Form 10-K Cardlytics, Inc. For: Dec 31

Go back to Form 10-K Cardlytics, Inc. For: Dec 31

Cardlytics (CDLX) PT Lowered to $3 at Evercore ISI

March 13, 2025 10:02 AM EDT

Evercore ISI analyst Mark Mahaney lowered the price target on Cardlytics (NASDAQ: CDLX) to $3.00 (from $4.00) while maintaining a In Line rating.

The analyst comments "Our View: We maintain our In Line rating but lower our price target to $3 (from $4... More

Cardlytics (CDLX) PT Lowered to $2.50 at BofA Securities

March 13, 2025 6:50 AM EDT

BofA Securities analyst Omar Dessouky lowered the price target on Cardlytics (NASDAQ: CDLX) to $2.50 (from $4.00) while maintaining a Underperform rating.

The analyst comments "4Q Revenue/Adj. Contribution ($74mn/$41mn) both landed above the high end of guidance ($67mn/$36mn), with EBITDA also... More